There are 2867 resources available
1158P - Study of patients’ characteristics associated with osimertinib outcomes upfront or in following lines in EGFR-positive NSCLC
Presenter: Edouard Auclin
Session: Poster session 16
1159P - The immune checkpoint inhibitors induced endocrinopathies and their effect on prognosis in advanced non-small cell lung cancer patients
Presenter: Minkwan Jo
Session: Poster session 16
1160P - Survival impact of second-line immune checkpoint inhibitors in the elderly patients with advanced squamous non-small cell lung cancer: Post-hoc analysis from a CAPITAL study
Presenter: Yoshihito Kogure
Session: Poster session 16
1161P - Clinical outcomes of bronchoscopic cryotherapy for malignant central airway obstruction in patients with non-small cell lung cancer
Presenter: Jiwon Kim
Session: Poster session 16
1162P - Tissue and liquid biopsy utilization in advanced NSCLC in a large community US practice
Presenter: Lucio Gordan
Session: Poster session 16
1163P - Impact of brain metastases in synchronous single organ oligometastatic lung cancer (OMD)
Presenter: Hevron Al Sheik
Session: Poster session 16
1164P - Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)
Presenter: Martin Sebastian
Session: Poster session 16
1165P - Incidence of clinically relevant hyperglycaemia in patients with non-small cell lung cancer treated with immunotherapy
Presenter: Sheima Farag
Session: Poster session 16
1166P - Social determinants of lung cancer in East London
Presenter: Catarina Alves Soares
Session: Poster session 16
1167P - Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis
Presenter: Sora Kang
Session: Poster session 16